1. Pacheco-Barrios K, Cardenas-Rojas A, Thibaut A, et al. Methods and strategies of tDCS for the treatment of pain: current status and future directions. Expert Rev Med Devices. 2020;17:879 −98.

2. Torres ILS, Cucco SNS, Bassani M, et al. Long-lasting delayed hyperalgesia after chronic restraint stress in rats - effect of morphine administration. Neurosci Res. 2003;45:277−83.

3. Timmers I, Quaedflieg CWEM, Hsu C, Heathcote LC, Rovnaghi CR, Simons LE. The interaction between stress and chronic pain through the lens of threat learning. Neurosci Biobehav Rev. 2019;107:641−55.

4. Adachi LNS, Quevedo AS, Souza A, Scarabelot VL, Rozisky JR, de Oliveira C, et al. Exogenously induced brain activation regulates neuronal activity by top‑down modulation: conceptualized model for electrical brain stimulation. Exp Brain Res. 2015;233:1377−89.

5. Vanderwall AG, Milligan ED. Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management. Front Immunol. 2019;10:3009.

6. Hua T, Chen B, Lu D, Sakurai K, Zhao S, Han BX, et al. General Anesthetics Activate a Potent Central Pain-Suppression Circuit in the Amygdala. Nat Neurosci. 2020;23:854−68.

7. Lopes BC, Medeiros LF, Souza VS, Cioato SG, Medeiros HR, Regner GG, et al. Transcranial direct current stimulation combined with exercise modulates the inflammatory profile and hyperalgesic response in rats subjected to a neuropathic pain model: Long-term effects. Brain Stimul. 2020;13:774−82.

8. Bennett GJ, Xie YK. A Peripheral Mononeuropathy in Rat That Produces Disorders of Pain Sensation Like Those Seen in Man. Pain. 1988;34:87−107.

9. Hung AL, Lim M, Doshi TL. Targeting cytokines for treatment of neuropathic pain. Scand J Pain. 2017;17:287−93.

10. Okamoto K, Martin DP, Schmelzer JD, Mitsui T, Low PA. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol. 2001;169:386−91.